Literature DB >> 671221

Pharmacokinetics of cefamandole using a HPLC assay.

N S Aziz, J G Gambertoglio, E T Lin, H Grausz, L Z Benet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 671221     DOI： 10.1007/BF01117449

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  20 in total

Review 1.  Pharmacokinetics and clinical use of cephalosporin antibiotics.

Authors:  C H Nightingale; D S Greene; R Quintiliani
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  Pharmacological studies with cefamandole in human volunteers.

Authors:  B R Meyers; B Ribner; S Yancovitz; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

3.  Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

Authors:  E C Ernst; S Berger; M Barza; N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

4.  Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance.

Authors:  C M Findell; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

5.  General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors:  L Z Benet
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

6.  In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.

Authors:  N K Shemonsky; J Carrizosa; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

7.  In vitro studies of cefamandole.

Authors:  G P Bodey; S Weaver
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

8.  Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

9.  Concentration of cefamandole in serum interstitial fluid, bile, and urine.

Authors:  N G Waterman; H U Eickenberg; L Scharfenberger
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191
View more
  12 in total

Review 1.  Benet L Z and Galeazzi R L: noncompartmental determination of the steady-state volume of distribution, J Pharm Sci 68, 1071-1074, 1979--the backstory.

Authors:  Leslie Z Benet
Journal:  AAPS J       Date:  2012-06       Impact factor: 4.009

2.  Semiparametric mixed-effects analysis of PK/PD models using differential equations.

Authors:  Yi Wang; Kent M Eskridge; Shunpu Zhang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-09-10       Impact factor: 2.745

3.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

4.  Pharmacokinetics of cefmetazole administered intramuscularly and intravenously to healthy adults.

Authors:  J Rodriguez-Barbero; E L Mariño; A Dominguez-Gil
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

5.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? II. The response mapping operator (RMO) approach.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

Review 6.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

7.  Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.

Authors:  S L Barriere; G J Hatheway; J G Gambertoglio; E T Lin; J E Conte
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

8.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.

Authors:  W R Gillespie; P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

9.  Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays.

Authors:  R W Bundtzen; R D Toothaker; O S Nielson; P O Madsen; P G Welling; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

10.  Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate.

Authors:  L Maass; V Malerczyk; M Verho; P Hajdú; K Seeger; N Klesel
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.